Health
Chinese-developed inactivated vaccine has low rate of adverse reactions – Global Times
A Chinese-developed inactivated COVID-19 vaccine on Thursday revealed a low rate of adverse reactions for patients in phase one and two clinical trials while also demonstrating immunogenicity results. The interim analysis of two randomized clinical trials sug…
vaccine Photo:VCG
A Chinese-developed inactivated COVID-19 vaccine on Thursday revealed a low rate of adverse reactions for patients in phase one and two clinical trials while also demonstrating immunogenicity results. The interim analysis of two randomized clinical trials suggests a relatively better safety profile compared with other kinds of the same type of vaccine, researchers said in the latest report.The report, published in peer-reviewed medical journal The Journal of the American Medic…
-
General23 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News10 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General22 hours agoAn open letter to pro-Palestinian protesters
-
Business12 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400